Submissions from 2025
Switching from Dupilumab to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: A Podcast Article, Vivian Y. Shi, Erman Güler, Brian Esparza, and Jonathan I. Silverberg
Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications, Lara Shqair, Iyla Draw, Tala Maya, Christopher G. Bunick, Hossein Akbarialiabad, Todd Schlesinger, Giovanni Damiani, Mahmoud Ghannoum, and Ayman Grada
Burden of mild and moderate atopic dermatitis in adults: results from a real-world study in the United States, Jonathan I. Silverberg, Peter Anderson, Joseph C. Cappelleri, James Piercy, Mark E. Levenberg, Daniela E. Myers, and Robert A. Gerber
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy, Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, Lisa Beck, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Alan D. Irvine, Peter Foley, James Del Rosso, Linda Stein Gold, Erin Johansson, Martin Dossenbach, Gaia Gallo, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Tristan Curteis, and Raj Chovatiya
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy, Jonathan I. Silverberg, Thomas Bieber, Amy S. Paller, Lisa Beck, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Alan D. Irvine, Peter Foley, James Del Rosso, Linda Stein Gold, Erin Johansson, Martin Dossenbach, Gaia Gallo, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Tristan Curteis, and Raj Chovatiya
Atopic dermatitis starting in childhood has a stronger impact on adults: results from the "Scars of Life" international project in 27 countries, Jonathan I. Silverberg, Roni Dodiuk-Gad, Roberto Takaoka, Jerry Tan, Chaoying Gu, Thomas Luger, Bruno Halioua, Flavia Aslanian, Cita Rosita Prakoeswa, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Nabil Kerrouche, Stéphanie Methand, Wendy Smith Begolka, África Luca Smith, Shulamit Burstein, Delphine Kerob, Charles Taieb, Charbel Skayem, Therdpong Tempark, Abraham Getachew Kelbore, Alexander Stratigos, Martin Steinhoff, Julien Seneschal, and Laurent Misery
Orismilast, a PDE4B/D inhibitor, in moderate-to-severe atopic dermatitis: Efficacy and safety from a multicenter, randomized, placebo-controlled, phase 2b dose-ranging study (ADESOS), Jonathan I. Silverberg, Lawrence F. Eichenfield, Andrew Blauvelt, Alan D. Irvine, Emma Guttman-Yassky, Richard G. Langley, Richard B. Warren, Lars E. French, Jakob Felding, Anne Weiss, Claus B. Pedersen, Morten L. Jensen, Anna Carlsson, Morten O. Sommer, Kim Kjøller, and Eric L. Simpson
Patients' Experiences of Atopic Dermatitis and Nemolizumab Treatment: An In-Trial Interview Study Embedded in a Phase 3 Clinical Trial (ARCADIA), Jonathan I. Silverberg, Dina Filipenko, Carla Dias Barbosa, Danielle Rodriguez, Olivier Chambenoit, Katrin Jack, Christophe Piketty, Ram Subramanian, and Jorge Puelles
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2), Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, Brad Glick, Petra Staubach, Brian Calimlim, Chao Li, Ayman Grada, Alvaro Moreira, Wan-Ju Lee, and Andreas Wollenberg
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis, Jonathan I. Silverberg, Melinda Gooderham, Andreas Wollenberg, Andrew E. Pink, Diego Ruiz Dasilva, Shawn G. Kwatra, Yousef Binamer, Norito Katoh, Valeria Aoki, Alvaro Moreira, Ayman Grada, Chao Li, Brian Calimlim, Wan-Ju Lee, and Christopher G. Bunick
Atopic Dermatitis and Parental Guilt in the United States: Results of a Nationwide Study, Jonathan I. Silverberg, Delphine Kerob, Caroline Le Floc'h, Charles Taieb, Wendy Smith Begolka, Ann'Laure Demessant-Flavigny, and Charbel Skayem
Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Danielle N. Rodriguez, Carla Dias-Barbosa, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles
Psychometric Validation of the Subject Sleep Diary in Patients with Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Danielle N. Rodriguez, Carla Dias-Barbosa, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles
Prevalence, severity and predictors of hand eczema in patients treated for atopic dermatitis: a cross-sectional observational study, Jonathan I. Silverberg, Archana Samynathan, and Jacob P. Thyssen
Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative Review, Jonathan I. Silverberg, Eric Simpson, Melinda Gooderham, Stephan Weidinger, Melissa Watkins, and Justine Alderfer
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE, Jonathan I. Silverberg, Eric L. Simpson, Andrew E. Pink, Stephan Weidinger, Gary Chan, Pinaki Biswas, Claire Clibborn, and Erman Güler
Chronic skin conditions and life trajectories: development and validation of "Dermatology Long-Term Life Impact Measure (DLLIM)", Jonathan I. Silverberg, Charbel Skayem, Ann'Laure Demessant Flavigny, Caroline Le Floc'h, Stéphanie Methand, Wendy Smith Begolka, África Luca Smith, Shulamit Burstein, Claire Della Vedova, Emmanuel Chamorey, Delphine Kerob, Charles Taieb, and Khaled Ezzedine
Nearly Half of American Children with Atopic Dermatitis Experience Significant Quality of Life Impairment, Often Underestimated by Parents, Jonathan I. Silverberg, Charbel Skayem, Caroline Le Floc'h, Wendy Smith Begolka, Charles Taieb, Ann'Laure Demessant-Flavigny, Delphine Kerob, and Andrew Y. Finlay
Response to Letter to the Editor from Dr. Paul et al, Jonathan I. Silverberg, Liliana Ulianov, and Christophe Piketty
Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis, Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, Gil Yosipovitch, Peter Lio, Christian Vestergaard, Sonja Ständer, Jose Manuel Carrascosa, Gaia Gallo, Marta Casillas, Yuxin Ding, Fan Emily Yang, Evangeline Pierce, Helena Agell, and James Del Rosso
Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial, Eric L. Simpson, Lawrence F. Eichenfield, Kim A. Papp, Seth B. Forman, Adelaide A. Hebert, Mercedes E. Gonzalez, Melinda J. Gooderham, H Chih-Ho Hong, Vimal H. Prajapati, Emma Guttman-Yassky, Jonathan I. Silverberg, Melissa S. Seal, David Krupa, Erin Almaraz, Diane Hanna, Patrick Burnett, Scott Snyder, David H. Chu, Robert C. Higham, and David R. Berk
Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis?, Eric L. Simpson, Jonathan I. Silverberg, Bob Geng, José-Manuel Carrascosa, Thomas Bieber, Patrick M. Brunner, Delphine Staumont-Sallé, Chao Ji, Pinaki Biswas, Claire Feeney, Irene Hernández-Martín, Francisco José Rebollo Laserna, and Herwig Koppensteiner
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis, Eric L. Simpson, Jonathan I. Silverberg, Vimal H. Prajapati, Kilian Eyerich, Norito Katoh, Mark Boguniewicz, Emma Guttman-Yassky, E James Song, Wan-Ju Lee, Henrique D. Teixeira, Tianshuang Wu, Cristina Sancho Sanchez, Namita Vigna, Brian M. Calimlim, and Marjolein de Bruin-Weller
Enhanced metastatic risk stratification for Cutaneous Squamous Cell Carcinoma by combining clinical guidelines with the Erasmus MC model: Results from Two Nationwide Nested Case-Control Studies, O F. Steijlen, L Pozza, J J. Traets, B Rentroia-Pacheco, C J. Eggermont, D Bellomo, S Alex, V A. Patel, A L. Mooyaart, L M. Hollestein, and M Wakkee
Response to [Zheng et al.,] "Letter to "Enhanced metastatic risk stratification for Cutaneous Squamous Cell Carcinoma by combining clinical guidelines with the Erasmus MC model".", Olivia F. Steijlen, Lara Pozza, Joleen J. Traets, Barbara Rentroia-Pacheco, Celeste J. Eggermont, Domenico Bellomo, Sheril Alex, Vishal A. Patel, Antien L. Mooyaart, Loes M. Hollestein, and Marlies Wakkee
Assessing vulvar dermatology education in medical school preclinical and clinical curriculum, Kennedy H. Sun, Rachel Bernardo, Scarlett J. Bergam, Yagiz Matthew Akiska, Allison Etcheverry, and Emily Murphy
Assessing vulvar dermatology education in medical school preclinical and clinical curriculum, Kennedy H. Sun, Rachel Bernardo, Scarlett J. Bergam, Yagiz Matthew Akiska, Allison Etcheverry, and Emily Murphy
Perioperative Treatment Strategies for Advanced Melanoma and Non-Melanoma Skin Cancers, Kennedy H. Sun, Sach Thakker, Jonathan Greenzaid, Micah Belzberg, David M. Miller, and Vishal A. Patel
Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Clinical Presentation, and Diagnosis, Sach Thakker, Daniella Jaguan, Micah Belzberg, Nina Gulati, Janeth R. Campbell, Brittney K. DeClerck, Gino K. In, and Vishal A. Patel
An Ethical Framework for Managing Neglected Skin Tumors in Older Patients, Sach Thakker, Kira Minkis, Shari R. Lipner, Nicholas Gulati, Vishal A. Patel, and Jafar Al-Mondhiry
Prevalence and Characteristics of Chronic Hand Eczema Among Adults in Denmark: A General Population-Based Study, David Thein, Julia-Tatjana Maul, Simone Ribero, Jonathan I. Silverberg, Alexander Egeberg, and Jacob P. Thyssen
Lichen Planus: A Cross-Sectional Evaluation of US Dermatologists' Comorbidity Screening and Management Patterns, Savanna I. Vidal, Nikita Menta, and Adam Friedman
Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape, Savanna I. Vidal, Nikita Menta, and Lawrence Green
Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape, Savanna I. Vidal, Nikita Menta, and Lawrence Green
Rademikibart monotherapy for moderate-to-severe atopic dermatitis in a 1-year, randomized, phase II trial (SEASIDE CHINA): initial two-week dosing, followed by two-week or four-week dosing, Jianzhong Zhang, Jonathan I. Silverberg, Jiawang Guo, Jili Yun, Wuban Pan, Zheng Wei, and Raúl Collazo
Submissions from 2024
Applications of nitric oxide-releasing nanomaterials in dermatology: Skin infections and wound healing, Sara Abdel Azim, Cleo Whiting, and Adam J. Friedman
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial, April W. Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman, Lawrence Green, Vivian Laquer, Xinyan Zhang, Nathalie Franchimont, Esha A. Gangolli, Jessamyn Blau, Yiwei Zhao, Wenwen Zhang, Bhaskar Srivastava, Graham Heap, and Kim Papp
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial, April W. Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman, Lawrence Green, Vivian Laquer, Xinyan Zhang, Nathalie Franchimont, Esha A. Gangolli, Jessamyn Blau, Yiwei Zhao, Wenwen Zhang, Bhaskar Srivastava, Graham Heap, and Kim Papp
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis, April W. Armstrong, H Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, and Jonathan I. Silverberg
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis, April W. Armstrong, H Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, and Jonathan I. Silverberg
Evaluating the Readability of the iPledge Comprehension Assessment and its Impact on Isotretinoin Accessibility, Peter Baek, Nidhi Shah, and A Yasmine Kirkorian
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial, Andrew Blauvelt, Zoe D. Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Janet DuBois, Seth B. Forman, Melinda Gooderham, Lawrence Green, Scott T. Guenthner, Adelaide A. Hebert, Edward Lain, Angela Y. Moore, Kim A. Papp, Matthew Zirwas, Saori Kato, Scott Snyder, David Krupa, Patrick Burnett, David R. Berk, and David H. Chu
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis, Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, and Jonathan I. Silverberg
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis, Andrew Blauvelt, Kilian Eyerich, Alan D. Irvine, Marjolein de Bruin-Weller, Shawn G. Kwatra, Melinda Gooderham, Brian Kim, Brian M. Calimlim, Wan-Ju Lee, Eliza M. Raymundo, Yingyi Liu, Sarah Ofori, Andrew M. Platt, and Jonathan I. Silverberg
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial, Andrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartlomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D. Charles, Claudia H. De Oliveira, and Jonathan I. Silverberg
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial, Andrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, Saakshi Khattri, Joel Schlessinger, Shinichi Imafuku, Yayoi Tada, Akimichi Morita, Marni Wiseman, Bartlomiej Kwiek, Martina Machkova, Peijin Zhang, Misti Linaberry, Jie Li, Sandra Zhang, Giovanni Franchin, Edgar D. Charles, Claudia H. De Oliveira, and Jonathan I. Silverberg
Executive summary: Consensus treatment guidelines for the use of methotrexate for inflammatory skin disease in pediatric patients, Heather A. Brandling-Bennett, Lisa M. Arkin, Yvonne E. Chiu, Adelaide A. Hebert, Jeffrey P. Callen, Leslie Castelo-Soccio, Dominic O. Co, Kelly M. Cordoro, Megan L. Curran, Austin M. Dalrymple, Carsten Flohr, Ken B. Gordon, Diane Hanna, Alan D. Irvine, Susan Kim, A Yasmine Kirkorian, Irene Lara-Corrales, Jill Lindstrom, Amy S. Paller, Melissa Reyes, Wendy Smith Begolka, Wynnis L. Tom, Abby S. Van Voorhees, Ruth Ann Vleugels, Lara Wine Lee, Olivia Davies, and Elaine C. Siegfried
Association of alopecia areata and ischemic heart disease and cerebrovascular in U.S. adults: an all of us database study, Stella Caldas, Angel D. Pagan, Juliana Pulsinelli, Joel Correa da Rosa, Seungyeon Jung, Divija Sharma, Jonas A. Adalsteinsson, and Benjamin Ungar
Pediatric Cutaneous T-Cell Neoplasms: Clinical and Pathological Features, Updated Classifications, and Critical Differential Diagnoses, Jinjun Cheng, Birte Wistinghausen, and A Yasmine Kirkorian
Attitudes, practices, facilitators, and barriers to sexual orientation and gender identity data collection in dermatology practices, Richard Chen, Temi Adekunle, Lena Chu, Ronnie Festok, Julia L. Gao, Daniel A. Yanes, Erica D. Dommasch, John G. Zampella, and Howa Yeung
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC, Shayan Cheraghlou, Mary L. Stevenson, Sean R. Christensen, Jeremy S. Bordeaux, Joanna L. Walker, Divya Srivastava, Carla Ferrándiz-Pulido, Kristin P. Bibee, Joi B. Carter, Faramarz H. Samie, Vishal A. Patel, Bryan T. Carroll, Allison T. Vidimos, Christian L. Baum, Justin J. Leitenberger, Anokhi Jambusaria-Pahlajani, Emily S. Ruiz, John A. Carucci, David R. Carr, and Kathryn T. Shahwan
Standardizing Retrospective Observational Research in Cutaneous Squamous Cell Carcinoma: Expert Panel Guidelines from ITSCC, Shayan Cheraghlou, Mary L. Stevenson, Sean R. Christensen, Jeremy S. Bordeaux, Joanna L. Walker, Divya Srivastava, Carla Ferrándiz-Pulido, Kristin P. Bibee, Joi B. Carter, Faramarz H. Samie, Vishal A. Patel, Bryan T. Carroll, Allison T. Vidimos, Christian L. Baum, Justin J. Leitenberger, Anokhi Jambusaria-Pahlajani, Emily S. Ruiz, John A. Carucci, David R. Carr, and Kathryn T. Shahwan
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations, Derek K. Chu, Lynda Schneider, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Stephen A. Martin, Monica O'Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Kathryn E. Wheeler, and Gordon H. Guyatt
Photopatch testing: Clinical characteristics, test results, and final diagnoses from the North American Contact Dermatitis Group, 2009-2020, Vincent A. DeLeo, Brandon L. Adler, Donald V. Belsito, Melanie D. Pratt, Denis Sasseville, Margo J. Reeder, Erin M. Warshaw, Amber R. Atwater, James S. Taylor, Frances Storrs, James G. Marks, Joel G. DeKoven, Jonathan Silverberg, JiaDe Yu, Nina Botto, Marie-Claude Houle, Christen M. Mowad, and Cory A. Dunnick
Isotretinoin for rosacea: A systematic review, Sapana Desai and Adam Friedman
Capturing patient-reported sleep disturbance in atopic dermatitis clinical trials, Carla Dias-Barbosa, Jonathan I. Silverberg, Sonja Ständer, Danielle Rodriguez, Fatoumata Fofana, Dina Filipenko, Liliana Ulianov, Christophe Piketty, and Jorge Puelles
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany, Nicholas Durno, Pablo Arija, Krystallia Pantiri, Marieke Heisen, Marco Boeri, Josef Paris, Katrin Jack, Olivier Chambenoit, Ramkumar Subramanian, Jorge Puelles, Elly Stolk, Ben van Hout, and Jonathan I. Silverberg
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and Germany, Nicholas Durno, Pablo Arija, Krystallia Pantiri, Marieke Heisen, Marco Boeri, Josef Paris, Katrin Jack, Olivier Chambenoit, Ramkumar Subramanian, Jorge Puelles, Elly Stolk, Ben van Hout, and Jonathan I. Silverberg
Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis, Lawrence F. Eichenfield, Jonathan I. Silverberg, Adelaide A. Hebert, and Mark Boguniewicz
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies, Lawrence F. Eichenfield, Eric L. Simpson, Kim Papp, Jacek C. Szepietowski, Andrew Blauvelt, Leon Kircik, Jonathan I. Silverberg, Elaine C. Siegfried, Michael E. Kuligowski, May E. Venturanza, Howard Kallender, Haobo Ren, and Amy S. Paller
Rx -to- OTC switch increased access and lowered cost of topical adapalene, William Fix, Sapana Desai, Dillon Nussbaum, and Adam Friedman
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria, Adam Friedman, Shawn G. Kwatra, and Gil Yosipovitch
A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria, Adam Friedman, Shawn G. Kwatra, and Gil Yosipovitch
Hailey-Hailey disease successfully treated with tralokinumab and literature review of successful treatment with dupilumab, Kareena S. Garg, Jonathan Silverberg, and Leonardo Tjahjono
Treatment of recalcitrant discoid lupus erythematosus with roflumilast 0.3% cream following suboptimal response to anifrolumab and improvement of hypopigmentation, Kareena S. Garg and Leonardo A. Tjahjono
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor), Melinda Gooderham, Ronald Vender, Jeffrey Crowley, H Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, and Lawrence Green
Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Papulopustular Rosacea in Elderly Patients: Post-hoc Analysis of Results from Two Randomized, Phase III, Vehicle-controlled Trials, Lawrence J. Green, Hilary Baldwin, Jeffrey Sugarman, Bill Andriopoulos, Ori Nov, Ofra Levy-Hacham, Neal Bhatia, and William P. Werschler
Response to Bass et al.'s "Significant discordance in DermTech test results when paired with histopathology: Caveat emptor.", Lawrence J. Green, Brook Brouha, and Neal Bhatia
Pediatric dermatologic emergencies, Juliana R. Gruver and A Yasmine Kirkorian
Pediatric dermatologic emergencies, Juliana R. Gruver and A Yasmine Kirkorian
A Practical Guide to Using Oral JAK Inhibitors for Atopic Dermatitis from the International Eczema Council, Carter Haag, Andrew Alexis, Valeria Aoki, Robert Bissonnette, Andrew Blauvelt, Raj Chovatiya, Michael J. Cork, Simon G. Danby, Lawrence Eichenfield, Kilian Eyerich, Melinda Gooderham, Emma Guttman-Yassky, Dirk-Jan Hijnen, Alan Irvine, Norito Katoh, Dedee F. Murrell, Yael A. Leshem, Adriane Levin, Ida Vittrup, Jill I. Olydam, Raquel L. Orfali, Amy Paller, Yael Renert-Yuval, David Rosmarin, Jonathan Silverberg, Jacob Thyssen, Sonja Ständer, Nick Stefanovic, Gail Todd, JiaDe Yu, and Eric Simpson
Use of advanced systemic therapy in patients with moderate-to-severe atopic dermatitis in the TARGET-DERM AD Registry, Michael A. Haft, Keith D. Knapp, Ami Claxton, Breda Munoz, Julie M. Crawford, Sanjeev Balu, Yestle Kim, Shannon Schneider, Dawn Z. Eichenfield, Jonathan I. Silverberg, Lawrence F. Eichenfield, Jerry Bagel, Jamie L. Rhoads, and Amy S. Paller
Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis, Stella P. Hartono, Sheena Chatrath, Ozge N. Aktas, Stephanie A. Kubala, Korey Capozza, Ian A. Myles, Jonathan I. Silverberg, and Alan Schwartz
Nonhealing vulvar ulcer associated with hyperkeratotic depigmented plaques, Shivani Jain, Sydney Rivera, Emily Murphy, and Melissa M. Mauskar
Nonhealing vulvar ulcer associated with hyperkeratotic depigmented plaques, Shivani Jain, Sydney Rivera, Emily Murphy, and Melissa M. Mauskar
Increased loss-of-function filaggrin gene mutation prevalence in atopic dermatitis patients across northern latitudes indicates genetic fitness: A systematic review and meta-analysis, Casper Milde Khatib, Amalie Wandel Klein-Petersen, Amalie Thorsti Rønnstad, Alexander Egeberg, Maria Oberländer Christensen, Jonathan Ian Silverberg, Simon Francis Thomsen, Alan David Irvine, and Jacob Pontoppidan Thyssen
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib, Shawn G. Kwatra, Marjolein De Bruin-Weller, Jonathan I. Silverberg, Peter Lio, Mette Deleuran, Handan Aydin, Brian M. Calimlim, Michael C. Lane, Yingyi Liu, Sarah Ofori, and Stephan Weidinger
Topical Nanoencapsulated Cannabidiol Cream as an Innovative Strategy Combatting Ultraviolet A-Induced Nuclear and Mitochondrial DNA Injury: A Pilot Randomized Clinical Study, Erika McCormick, Haowei Han, Sara Abdel Azim, Cleo Whiting, Nitish Bhamidipati, Alexi Kiss, Tatiana Efimova, Brian Berman, and Adam Friedman
Insights from a joint pediatric dermatology-gynecology vulvar clinic: A retrospective study, Nikita Menta, Dillon Nussbaum, Aneka Khilnani, Tazim Dowlut-McElroy, and Kaiane A. Habeshian
Atopic Dermatitis: A Disorder of both Adults and Children with Varying Longitudinal Course, Shanthi Narla and Jonathan I. Silverberg
Bed Bugs, Scott A. Norton and Richard J. Pollack
Bed Bugs, Scott A. Norton and Richard J. Pollack
Reducing disparities in the care of atopic dermatitis, Uchechi Nwaneri, Candrice Heath, Andrew Alexis, Adam Friedman, and Jonathan I. Silverberg
Association between body mass index and vitiligo distribution: An observational cohort study, Ross O'Hagan, Samir Kamat, Shira Wieder, Marcel Perl, Jonathan I. Silverberg, and Nanette B. Silverberg
An observational cohort study of body mass index in pediatric vitiligo, Ross O'Hagan, Shira Wieder, Marcel Perl, Jonathan I. Silverberg, and Nanette B. Silverberg
An observational cohort study of body mass index in pediatric vitiligo, Ross O'Hagan, Shira Wieder, Marcel Perl, Jonathan I. Silverberg, and Nanette B. Silverberg
Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis, Amy S. Paller, Lawrence J. Green, Nanette Silverberg, Stephen Stripling, Martina Cartwright, Carolyn Enloe, Nick Wells, Elaine Kearney Kowalewski, and Tomoko Maeda-Chubachi
Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years, Amy S. Paller, Jonathan I. Silverberg, Mercedes E. Gonzalez, Lynda C. Schneider, Robert Sidbury, Zhen Chen, Ashish Bansal, Zhixiao Wang, and Randy Prescilla
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study, Amy S. Paller, Jonathan I. Silverberg, Eric L. Simpson, Michael J. Cork, Peter D. Arkwright, Zhen Chen, Ashish Bansal, Randy Prescilla, Zhixiao Wang, and Ainara R. Marco
Evaluating the Content and Quality of the Top 50 #Cosmeticdermatology Instagram Posts, Vincent A. Pecora, Erika T. McCormick, Alexis E. Carrington, and Pooja Sodha
Targeting sebaceous glands: a review of selective photothermolysis for Acne Vulgaris treatment, Anika Pulumati, Dana Jaalouk, Yanci A. Algarin, Eli Kasheri, Naiem T. Issa, and Keyvan Nouri
Dermatologic Conditions in Down Syndrome: A Multi-Site Retrospective Review of International Classification of Diseases Codes, Tasya Rakasiwi, Chenin Ryan, Amy Stein, Alan Vu, Morgan Dykman, Ipsit Shah, Catherine Reilly, Gabrielle Brokamp, Mia A. Mologousis, Bailey Komishke, Vincent Hou, Sheilagh Maguiness, A Yasmine Kirkorian, Harper Price, Elena B. Hawryluk, Esteban Fernandez Faith, Irene Lara-Corrales, Emily Gurnee, Kristen E. Holland, and Jillian F. Rork
Occupational Contact Dermatitis in Construction Workers: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001-2020, Margo J. Reeder, Alexander Idrogo-Lam, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Jonathan I. Silverberg, Brandon L. Adler, Amber R. Atwater, James S. Taylor, Marie-Claude Houle, Donald V. Belsito, Jiade Yu, Nina Botto, Christen M. Mowad, Cory A. Dunnick, Vincent A. DeLeo, and Melanie D. Pratt
Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019-2020, Margo J. Reeder, Aman Nihal, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Marie-Claude Houle, Brandon L. Adler, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Donald V. Belsito, Jiade Yu, Nina B. Botto, Chris M. Mowad, Cory A. Dunnick, and Vincent A. DeLeo
Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019-2020, Margo J. Reeder, Aman Nihal, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Marie-Claude Houle, Brandon L. Adler, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Donald V. Belsito, Jiade Yu, Nina B. Botto, Chris M. Mowad, Cory A. Dunnick, and Vincent A. DeLeo
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients, Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, David Rosmarin, Lawrence F. Eichenfield, Leslie Castelo-Soccio, Victor Huang, Seemal R. Desai, Samantha Walsh, Jonathan I. Silverberg, Amy S. Paller, Michele Rodrigues, Mark Weingarten, Shanthi Narla, Jackie Gardner, Michael Siegel, Sidra Ibad, and Nanette B. Silverberg
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients, Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, David Rosmarin, Lawrence F. Eichenfield, Leslie Castelo-Soccio, Victor Huang, Seemal R. Desai, Samantha Walsh, Jonathan I. Silverberg, Amy S. Paller, Michele Rodrigues, Mark Weingarten, Shanthi Narla, Jackie Gardner, Michael Siegel, Sidra Ibad, and Nanette B. Silverberg
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study, Amalie Thorsti Rønnstad, Mia-Louise Nielsen, Christoph Schlapbach, Emma Guttman-Yassky, Jonathan I. Silverberg, Simon Francis Thomsen, Jacob P. Thyssen, and Alexander Egeberg
Navigating the atopic dermatitis toolbox: Challenging scenarios and shared decision-making, Archana Samynathan and Jonathan I. Silverberg
A review of hair removal modalities in pediatric patients: Ethical and clinical considerations, Eric Sanfilippo, Leslie Castelo-Soccio, and Anna Yasmine Kirkorian